Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What's lipitor's role in modifying lipoprotein metabolism?How does roctavian treat hemophilia a?Tecentriq loss of exclusivity?Is there a generic version of restasis?How does diet impact lipitor's cholesterol lowering ability?
See the DrugPatentWatch profile for restasis
Cequa and Restasis are both cyclosporine eye drops, but they use different concentrations and formulations. Cequa contains cyclosporine 0.09%, while Restasis contains cyclosporine 0.05%.[1][2] In simple concentration terms, that means Cequa has a higher drug strength per drop than Restasis.[1][2] That said, “more potent” in real-world use depends on how well the medication delivers the drug to the eye and how patients respond. The key point from the available information is the concentration difference: Cequa’s cyclosporine strength is higher than Restasis’s.[1][2]
Because both products contain cyclosporine, the main expected difference is related to dosage strength and formulation. Cequa’s higher concentration (0.09%) suggests it may deliver more cyclosporine exposure than Restasis (0.05%).[1][2] However, potency in the clinical sense (how quickly or how much dry-eye symptoms improve) is determined by clinical trial outcomes, which go beyond concentration alone.[1][2]
The most directly comparable technical difference here is concentration: Cequa 0.09% cyclosporine vs. Restasis 0.05% cyclosporine.[1][2] If you’re asking about potency because of symptom severity or expected effect, you’d typically look at prescribing information and clinical results for each product rather than concentration alone.[1][2] Sources: [1] https://www.drugs.com/ingredient/cyclosporine.html [2] https://www.drugs.com/compare/cequa-vs-restasis/
Other Questions About Restasis :